3,270
Views
15
CrossRef citations to date
0
Altmetric
Original Investigation

Integrated analysis of human transcriptome data for Rett syndrome finds a network of involved genes

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 712-725 | Received 03 Oct 2018, Accepted 06 Mar 2019, Published online: 29 Apr 2019

References

  • Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 23:185–188.
  • Banerjee S, Crouse NR, Emnett RJ, Gianino SM, Gutmann DH. 2011. Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner. Proc Natl Acad Sci U S A. 108:15996–16001.
  • Bedogni F, Rossi RL, Galli F, Cobolli Gigli C, Gandaglia A, Kilstrup-Nielsen C, Landsberger N. 2014. Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action. Neurosci Biobehav Rev. 46 Pt 2:187–201.
  • Cartron PF, Nadaradjane A, Lepape F, Lalier L, Gardie B, Vallette FM. 2013. Identification of TET1 partners that control its DNA-demethylating function. Genes Cancer. 4:235–241.
  • Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY. 2008. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 320:1224–1229.
  • Chang RC, Yu MS, Lai CS. 2006. Significance of molecular signaling for protein translation control in neurodegenerative diseases. Neurosignals. 15:249–258.
  • Ch'ng C, Kwok W, Rogic S, Pavlidis P. 2015. Meta-analysis of gene expression in autism spectrum disorder. Autism Res. 8:593–608.
  • Colantuoni C, Jeon OH, Hyder K, Chenchik A, Khimani AH, Narayanan V, Hoffman EP, Kaufmann WE, Naidu S, Pevsner J. 2001. Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis. 8:847–865.
  • Deng V, Matagne V, Banine F, Frerking M, Ohliger P, Budden S, Pevsner J, Dissen GA, Sherman LS, Ojeda SR. 2007. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet. 16:640–650.
  • Edgar R, Domrachev M, Lash AE. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30:207–210.
  • Ehrhart F, Coort SL, Cirillo E, Smeets E, Evelo CT, Curfs LM. 2016. Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes. Orphanet J Rare Dis. 11:158.
  • Eijssen LM, Jaillard M, Adriaens ME, Gaj S, de Groot PJ, Muller M, Evelo CT. 2013. User-friendly solutions for microarray quality control and pre-processing on ArrayAnalysis.org. Nucleic Acids Res. 41:W71–W76.
  • Gold WA, Lacina TA, Cantrill LC, Christodoulou J. 2015. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors. J Mol Med. 93:63–72.
  • Gonzales ML, Adams S, Dunaway KW, LaSalle JM. 2012. Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation. Mol Cell Biol. 32:2894–2903.
  • Jordan C, Li HH, Kwan HC, Francke U. 2007. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med Genet. 8:36.
  • Kutmon M, Kelder T, Mandaviya P, Evelo CT, Coort SL. 2013. CyTargetLinker: a cytoscape app to integrate regulatory interactions in network analysis. PLoS One. 8:e82160.
  • Kutmon M, van Iersel MP, Bohler A, Kelder T, Nunes N, Pico AR, Evelo CT. 2015. PathVisio 3: an extendable pathway analysis toolbox. PLoS Comput Biol. 11:e1004085.
  • Kutmon M, Ehrhart F, Willighagen EL, Evelo CT, Coort SL. 2018. CyTargetLinker app update: A flexible solution for network extension in Cytoscape. F1000Res 7:743. doi:10.12688/f1000research.14613.1
  • Laurvick CL, de Klerk N, Bower C, Christodoulou J, Ravine D, Ellaway C, Williamson S, Leonard H. 2006. Rett syndrome in Australia: a review of the epidemiology. J Pediatr. 148:347–352.
  • Le Meur N, Holder-Espinasse M, Jaillard S, Goldenberg A, Joriot S, Amati-Bonneau P, Guichet A, Barth M, Charollais A, Journel H, et al. 2010. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. J Med Genet. 47:22–29.
  • Li J, Shi M, Ma Z, Zhao S, Euskirchen G, Ziskin J, Urban A, Hallmayer J, Snyder M. 2014. Integrated systems analysis reveals a molecular network underlying autism spectrum disorders. Mol Syst Biol. 10:774.
  • Li Y, Wang H, Muffat J, Cheng AW, Orlando DA, Loven J, Kwok SM, Feldman DA, Bateup HS, Gao Q, et al. 2013. Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell. 13:446–458.
  • Lin P, Nicholls L, Assareh H, Fang Z, Amos TG, Edwards RJ, Assareh AA, Voineagu I. 2016. Transcriptome analysis of human brain tissue identifies reduced expression of complement complex C1Q Genes in Rett syndrome. BMC Genomics. 17:427.
  • Liyanage VR, Rastegar M. 2014. Rett syndrome and MeCP2. Neuromolecular Med. 16:231–264.
  • Long SW, Ooi JY, Yau PM, Jones PL. 2011. A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing. Biosci Rep. 31:333–343.
  • Miller RA, Ehrhart F, Eijssen LMT, Slenter DN, Curfs LMG, Evelo CT, Willighagen EL, Kutmon M. 2018. Beyond pathway analysis: Identification of active subnetworks in Rett syndrome. Front Genet. (accepted).
  • Mistry M, Gillis J, Pavlidis P. 2013. Genome-wide expression profiling of schizophrenia using a large combined cohort. Mol Psychiatry. 18:215–225.
  • Miyano M, Horike S, Cai S, Oshimura M, Kohwi-Shigematsu T. 2008. DLX5 expression is monoallelic and Dlx5 is up-regulated in the Mecp2-null frontal cortex. J Cell Mol Med. 12:1188–1191.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6:e1000097.
  • Muller-McNicoll M, Botti V, de Jesus Domingues AM, Brandl H, Schwich OD, Steiner MC, Curk T, Poser I, Zarnack K, Neugebauer KM. 2016. SR proteins are NXF1 adaptors that link alternative RNA processing to mRNA export. Genes Dev. 30:553–566.
  • Muotri AR, Marchetto MC, Coufal NG, Oefner R, Yeo G, Nakashima K, Gage FH. 2010. L1 retrotransposition in neurons is modulated by MeCP2. Nature. 468:443–446.
  • Nectoux J, Fichou Y, Rosas-Vargas H, Cagnard N, Bahi-Buisson N, Nusbaum P, Letourneur F, Chelly J, Bienvenu T. 2010. Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes. J Cell Mol Med. 14:1962–1974.
  • Nguyen MV, Du F, Felice CA, Shan X, Nigam A, Mandel G, Robinson JK, Ballas N. 2012. MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J Neurosci. 32:10021–10034.
  • Nomura T, Kimura M, Horii T, Morita S, Soejima H, Kudo S, Hatada I. 2008. MeCP2-dependent repression of an imprinted miR-184 released by depolarization. Hum Mol Genet. 17:1192–1199.
  • Pecorelli A, Cervellati C, Hayek J, Valacchi G. 2016. OxInflammation in Rett syndrome. Int J Biochem Cell Biol. 81:246–253.
  • Peddada S, Yasui DH, LaSalle JM. 2006. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum Mol Genet. 15:2003–2014.
  • Raddatz BB, Hansmann F, Spitzbarth I, Kalkuhl A, Deschl U, Baumgartner W, Ulrich R. 2014. Transcriptomic meta-analysis of multiple sclerosis and its experimental models. PLoS One. 9:e86643.
  • Rett A. 1966. [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. Wien Med Wochenschr. 116:723–726.
  • Ricciardi S, Boggio EM, Grosso S, Lonetti G, Forlani G, Stefanelli G, Calcagno E, Morello N, Landsberger N, Biffo S, et al. 2011. Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum Mol Genet. 20:1182–1196.
  • Roder C, Kasuya H, Harati A, Tatagiba M, Inoue I, Krischek B. 2012. Meta-analysis of microarray gene expression studies on intracranial aneurysms. Neuroscience. 201:105–113.
  • Rogic S, Pavlidis P. 2009. Meta-analysis of kindling-induced gene expression changes in the rat hippocampus. Front Neurosci. 3:53.
  • Rustici G, Kolesnikov N, Brandizi M, Burdett T, Dylag M, Emam I, Farne A, Hastings E, Ison J, Keays M, et al. 2013. ArrayExpress update-trends in database growth and links to data analysis tools. Nucleic Acids Res. 41:D987–9D990.
  • Schaffer AE, Eggens VR, Caglayan AO, Reuter MS, Scott E, Coufal NG, Silhavy JL, Xue Y, Kayserili H, Yasuno K, et al. 2014. CLP1 founder mutation links tRNA splicing and maturation to cerebellar development and neurodegeneration. Cell. 157:651–663.
  • Schule B, Li HH, Fisch-Kohl C, Purmann C, Francke U. 2007. DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 deficiency. Am J Hum Genet. 81:492–506.
  • Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504.
  • Signorini C, Leoncini S, De Felice C, Pecorelli A, Meloni I, Ariani F, Mari F, Amabile S, Paccagnini E, Gentile M, et al. 2014. Redox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome. Oxid Med Cell Longev. 2014:195935.
  • Smith RM, Sadee W. 2011. Synaptic signaling and aberrant RNA splicing in autism spectrum disorders. Front Synaptic Neurosci. 3:1.
  • Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. 2011. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 27:431–432.
  • Tanaka Y, Kim KY, Zhong M, Pan X, Weissman SM, Park IH. 2014. Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2). Hum Mol Genet. 23:1045–1055.
  • Traynor J, Agarwal P, Lazzeroni L, Francke U. 2002. Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med Genet. 3:12.
  • Uddin RK, Singh SM. 2013. Hippocampal gene expression meta-analysis identifies aging and age-associated spatial learning impairment (ASLI) genes and pathways. PLoS One. 8:e69768.
  • Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, et al. 2015. Proteomics. Tissue-based map of the human proteome. Science. 347:1260419.
  • van Iersel MP, Pico AR, Kelder T, Gao J, Ho I, Hanspers K, Conklin BR, Evelo CT. 2010. The BridgeDb framework: standardized access to gene, protein and metabolite identifier mapping services. BMC Bioinformatics. 11:5.
  • Young JI, Hong EP, Castle JC, Crespo-Barreto J, Bowman AB, Rose MF, Kang D, Richman R, Johnson JM, Berget S, et al. 2005. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci USA. 102:17551–17558.
  • Zambon AC, Gaj S, Ho I, Hanspers K, Vranizan K, Evelo CT, Conklin BR, Pico AR, Salomonis N. 2012. GO-Elite: a flexible solution for pathway and ontology over-representation. Bioinformatics. 28:2209–2210.
  • Zhang R, Lahens NF, Ballance HI, Hughes ME, Hogenesch JB. 2014. A circadian gene expression atlas in mammals: implications for biology and medicine. Proc Natl Acad Sci USA. 111:16219–16224.